Platinum Commercial Presentation: Cytek Biosciences
| Monday, August 28, 2023 |
| 11:20 AM - 11:55 AM |
Overview
Chair: Dr Matthew Linden
Speaker: Dr Kathryn Hally (UoO, Wellington, NZ): Certain monocyte-specific immune signatures are associated with cardiac repair in patients with Acute Myocardial Infarction.
Speaker: Dr Kathryn Hally (UoO, Wellington, NZ): Certain monocyte-specific immune signatures are associated with cardiac repair in patients with Acute Myocardial Infarction.
Details
Acute Myocardial Infarction (AMI) is a serious clinical condition associated with significant morbidity and mortality. The extent of cardiac repair is a critical determinant of a patient’s risk of experiencing recurrent complications and is driven, in part, by the immune response to AMI. Monocytes are a key driver of this response, and monocyte-specific biomarkers may provide a tool for predicting disease course in this context. In this presentation, we will discuss our development of a 21-marker, 18-colour immunophenotyping panel for deep monocyte analysis in human whole blood using spectral flow cytometry. We utilized this phenotyping panel to examine monocyte function during the acute phase of an AMI, and to determine monocyte-specific immune signatures associated with cardiac repair in patients with AMI.
Speaker
Dr Kathryn Hally
Lecturer
University of Otago
Certain monocyte-specific immune signatures are associated with cardiac repair in patients with Acute Myocardial Infarction (AMI).
11:20 AM - 11:55 AMBiography
Dr Kathryn Hally is a lecturer within the Department of Surgery and Anaesthesia at the University of Otago, Wellington. Her current research focuses on developing inflammation-based risk scores for predicting optimal recovery in patients with acute myocardial infarction. For her research, she uses spectral flow cytometry to interrogate circulating immune cell phenotype for biomarker discovery.
Chair
Matthew Linden
Associate Professor
University of Western Australia
